Here's What Analysts Are Asking Puma Biotech Following Roche's Positive Perjeta Results
March 02, 2017 at 12:07 PM EST
RBC Capital says the commercial opportunity for Puma Biotechnology Inc (NASDAQ: PBYI)’s breast cancer drug neratinib in the ...